Detail akcie Retractable Tech online

Business Summary: Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Retractable Technologies Inc revenues increased 20% to $28.8M. Net loss applicable to common stockholders decreased 34% to $10.4M. Revenues reflect United States segment increase of 18% to $25.1M, North and South America(excluding U.S) segment increase from $1.4M to $2.8M. Lower net loss reflects General and administrative decrease of 5% to $9.6M (expense).